Kintara Therapeutics to Present at the 8th Annual Dawson James Small Cap Growth ConferencePRNewsWire • 10/11/23
Kintara Therapeutics Presents Case Studies of Glioblastoma Patients Treated with VAL-083 at 2023 European Association for Neuro-Oncology Annual MeetingPRNewsWire • 09/25/23
Kintara Therapeutics Announces Fiscal 2023 Year Financial Results and Provides Corporate UpdatePRNewsWire • 09/18/23
Kintara Therapeutics to Present at the 2023 European Association for Neuro-Oncology Annual MeetingPRNewsWire • 09/05/23
Kintara Therapeutics to Host Virtual KOL Event on VAL-083, A Potential First-in-Class Small Molecule Chemotherapeutic for Glioblastoma, on August 21, 2023PRNewsWire • 08/17/23
Kintara Therapeutics to Participate in the Fifth Annual Glioblastoma Awareness Day in Washington, D.C.PRNewsWire • 07/19/23
Kintara Therapeutics Awarded $2.0 Million National Institutes of Health SBIR Grant to Support the Clinical Development of REM-001PRNewsWire • 06/28/23
Kintara Therapeutics to Participate in the Maxim Group Virtual Healthcare ConferencePRNewsWire • 06/16/23
Kintara Therapeutics to Commemorate National Brain Tumor Awareness Month with Ringing the Bell at Nasdaq Closing Along with Global Coalition for Adaptive Research and the National Brain Tumor SocietyPRNewsWire • 05/19/23
Kintara Therapeutics Announces Fiscal 2023 Third Quarter Financial Results and Provides Corporate UpdatePRNewsWire • 05/11/23
Kintara Therapeutics Announces Data Presentation at the 2023 American Association for Cancer Research Annual MeetingPRNewsWire • 04/14/23
Kintara Therapeutics to Present Two Posters at the 2023 American Association for Cancer Research Annual MeetingPRNewsWire • 03/15/23
Kintara Therapeutics Scheduled to Present at Two Conferences the Week of March 13, 2023PRNewsWire • 03/10/23
Kintara Therapeutics Announces Fiscal 2023 Second Quarter Financial Results and Provides Corporate UpdatePRNewsWire • 02/14/23
Kintara Therapeutics to Present at the Biotech Showcase Conference on January 10, 2023PRNewsWire • 01/09/23
Why Kintara Therapeutics Stock Is Seeing Blue Skies Thursday - Kintara Therapeutics (NASDAQ:KTRA)Benzinga • 12/15/22
Kintara Therapeutics Receives Orphan Drug Designation for VAL-083 for Treatment of Diffuse Intrinsic Pontine Glioma (DIPG)PRNewsWire • 12/15/22